Elion Therapeutics

Boston, MA · Founded 2018 · Privately Held (backing)

Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. Elion Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $163 million in Aug 2025. It has raised $111 million.

Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$111.0M
Last round
—

Who backs Elion Therapeutics?

3 investors
InvestorType
Deerfield ManagementVenture capital
Illinois VenturesOther
AMR Action Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Elion Therapeutics investors

3 investors are on record for Elion Therapeutics, including Deerfield Management, Illinois Ventures and AMR Action Fund.

Free account
More of Elion Therapeutics with a free account
  • ·Watch Elion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Elion Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View